A commercial brand of mouthwash that is readily available from supermarkets and pharmacies can help curb the growth of the bacteria responsible for gonorrhea, reveals preliminary research published online in the journal Sexually Transmitted Infections.
Daily rinsing and gargling with the product might be a cheap and easy way of helping to control the spread of the infection, suggest the researchers.
New cases of gonorrhea among men are on the rise in many countries amid declining condom use, with the bulk of cases among gay/bisexual men, say the researchers. Rising rates of gonorrhea heighten the risk of the emergence of antibiotic resistant strains of Neisseria gonnorhoeae, the bacteria responsible for the infection, making the need for a preventive measure that doesn't rely on condoms even more urgent, they say.
As far back as 1879, and before the advent of antibiotics, the manufacturer of Listerine, a commercial brand of mouthwash, claimed that it could be used to cure gonorrhea. But no published research has tested out this claim.
In a bid to rectify this, the researchers assessed whether Listerine could curb the growth of N. gonorrhoeae in laboratory tests and in sexually active gay/bisexual men in a clinical trial.
For the laboratory tests, different dilutions (up to 1:32) of Listerine Cool Mint and Total Care, both of which contain 21.6 percent alcohol, were applied to cultures of N. gonorrhoeae to see which of any of them might curb growth of the bacteria. By way of a comparison, a salt water (saline) solution was similarly applied to an identical set of cultures.
Listerine at dilutions of up to 1 in 4, applied for 1 minute, significantly reduced the number of N. gonorrhoeae on the culture plates, whereas the saline solution did not.
The clinical trial involved 196 gay/bisexual men who had previously tested positive for gonorrhea in their mouths/throat, and who were returning for treatment at one sexual health clinic in Melbourne, Australia, between May 2015 and February 2016.
Almost one-third (30 percent; 58) tested positive for the bacteria in their throat on the return visit.
Thirty three of these men were randomly assigned to a rinse and gargle with Listerine and 25 of them to a rinse and gargle with the saline solution.
After rinsing and gargling for 1 minute, the proportion of viable gonorrhea in the throat was 52 percent among the men using Listerine compared with 84 percent among those using saline.
And the men using Listerine were 80 percent less likely to test positive for gonorrhea in their throat five minutes after gargling than were the men using the saline solution.
The researchers admit that the monitoring period was short, so the possibility that the effects of the mouthwash might be short-lived can't be ruled out. But the laboratory test results would suggest otherwise, they say.
This research is preliminary, so a larger trial is currently under way to confirm these results and see whether the use of mouthwash could curb the spread of gonorrhea, they say.
"If daily use of mouthwash was shown to reduce the duration of untreated infection and/or reduce the probability of acquisition of N. gonorrhoeae, then this readily available, condom-less, and low cost intervention may have very significant public health implications in the control of gonorrhea in [men who have sex with men]," write the researchers.
Source: BMJ
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.